Latest Posts
When “Moderate” Isn’t Moderate: A New Way to Assess Risk in Aortic Stenosis
Read more: When “Moderate” Isn’t Moderate: A New Way to Assess Risk in Aortic StenosisThe moderate aortic stenosis risk score is a new clinical tool designed to predict who is truly at risk of cardiac death or heart failure hospitalisation — and who is likely to do well. If you have…
Cardio-Oncology Fellowship Training: Why a Full Year Matters
Read more: Cardio-Oncology Fellowship Training: Why a Full Year MattersDr Jonathan Sen explains why a full year of dedicated cardio-oncology fellowship, with integrated imaging and research at UHN Toronto, shapes better cardiac care for cancer patients in Brisbane.
Troponin Up on Immune Checkpoint Inhibitor: Panic, Pause, or Press On?
Read more: Troponin Up on Immune Checkpoint Inhibitor: Panic, Pause, or Press On?Immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment. By activating the immune system against tumours, they offer real hope across a growing number of malignancies. But that same immune activation can sometimes be directed…
The Intersection of Cancer and Heart Disease
Read more: The Intersection of Cancer and Heart DiseaseThanks to current advances in chemotherapy, immunotherapy, targeted therapies, and radiation techniques, five-year survival rates for a range of malignancies have improved dramatically—from 50% in the late 1980s to 72% in 2017–2021 (Australian Institute of Health and…
Welcome: Why I Became a Cardiologist that Cares About Cancer
Read more: Welcome: Why I Became a Cardiologist that Cares About CancerI remember the moment that changed how I think about medicine. A woman in her sixties had survived breast cancer, endured years of treatment, navigated the fear of recurrence, and finally achieved hard-won remission, only to develop…
